ArticleTechnology in cancer research & treatment

Inhibition of 6-Phosphogluconate Dehydrogenase Reverses Epirubicin Resistance Through Metabolic Reprograming in Triple-Negative Breast Cancer Cells.

Jiali Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.